The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2024 | ISTH 2024 highlights: promising upcoming treatments for hemophilia
Matteo Luciani, MD, Bambino Gesù Children’s Hospital, Rome, Italy, briefly discusses novel treatments being explored for patients with hemophilia, drawing focus on two agents: efanesoctocog alfa and Mim8. This interview took place at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Bangkok, Thailand, and virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
